SCHEMBL7007212

SCHEMBL7007212

O=S(=O)(Cl)c1ccccc1OCCN1CCOCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
DRD1 P21728 1/20 0.55
DRD4 P21917 1/20 0.55
DRD5 P21918 1/20 0.55
KDM4E B2RXH2 5/20 0.55
TSHR P16473 1/20 0.51
MAOB P27338 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
NFE2L2 Q16236 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14578233 0.78 DRD1 (0.65) POLBDRD1DRD4DRD5KDM4E
SCHEMBL23521620 0.77 KDM4E (0.54) POLBKDM4ETSHRCYP1A2CYP2D6
SCHEMBL6935354 0.76 DRD1 (0.71) POLBDRD1DRD4DRD5KDM4E
SCHEMBL4224048 0.76 DRD1 (0.63) POLBDRD1DRD4DRD5KDM4E
SCHEMBL240294 0.76 DRD1 (0.71) POLBDRD1DRD4DRD5KDM4E
SCHEMBL14059060 0.76 POLB (0.51) POLBDRD1DRD4DRD5KDM4E
SCHEMBL5319656 0.76 KDM4E (0.70) POLBDRD1DRD4DRD5KDM4E
SCHEMBL1853220 0.76 DRD1 (0.62) POLBDRD1DRD4DRD5KDM4E
SCHEMBL14396561 0.76 POLB (0.63) POLBDRD1DRD4DRD5KDM4E
SCHEMBL3405632 0.76 KDM4E (0.86) POLBDRD1DRD4DRD5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 US disclosed
EP-1105387-B1 PRODRUGS OF PROTON PUMP INHIBITORS WINSTON PHARMATEUTICALS LLC (US) 2003-01-29 EP disclosed
EP-1105387-A1 PRODRUGS OF PROTON PUMP INHIBITORS Partnership of Michael E. Garst, George Sachs and Jai Moo Shin (US) 2001-06-13 EP disclosed
WO-2000009498-A1 PRODRUGS OF PROTON PUMP INHIBITORS PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS AND JAI MOO SHIN (US) 2000-02-24 WO disclosed